HIPEC For Peritoneal Surface Malignancies Including Carcinomatosis or Sarcomatosis - Data Registry

Completed

Conditions studied: Peritoneal Neoplasms, Neoplasm Metastasis, Adenocarcinoma, Sarcoma

In brief

In this registry study the investigators will collect data about patients' disease, treatment, and response to treatment to include in both our local and national databases. These can then be used by investigators to answer questions about cytoreductive surgery/HIPEC such as how well-tolerated or effective it is in specific populations.

Key facts

Study ID

NCT02082886

Run by

Edward-Elmhurst Health System

People needed

193

Starts

2014-02-01

Expected to finish

2020-01-01

Last updated by the study team

2020-01-29

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Eligible to undergo cytoreductive surgery followed by HIPEC performed by the PI at Edward Hospital
• Provides consent by signing informed consent form

You may not qualify if…

• Not eligible for surgery or for potential cytoreductive surgery and/or HIPEC as determined by the PI
• Does not consent to participate

Where it is running

• Elmhurst Memorial Health Care — Elmhurst, Illinois, United States
• Edward Hospital — Naperville, Illinois, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.